Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab

OBJECTIVE: To evaluate prospectively serological markers at baseline and during treatment in patients with rheumatoid arthritis (RA) initiating rituximab treatment, following failure of antitumour necrosis factor (TNF)-α therapy. METHODS: Patients with RA and healthy control subjects were recruited....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Int Med Res
Hauptverfasser: Conigliaro, Paola, Triggianese, Paola, Chimenti, Maria Sole, Lucchetti, Ramona, Kroegler, Barbara, Perricone, Roberto
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2016
Schlagworte:
Immuno-Mediated Diseases and Treatment Immunogenicity
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536544/
https://ncbi.nlm.nih.gov/pubmed/27683140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060515593240
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge